DDInter1693 DDInter1676
Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 and by Health Canada on February 20, 2020. This drug is considered a _sphingosine-1-phosphate (S1P) receptor modulator_ and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS [FDA label]. Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that is chronic and inflammatory, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms between the age of 20 to 40, often the most productive years of life. Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings. MS is one of the most common causes of neurological disability in young adults and is found to occur more frequently in women than in men.[A176474,L5792]
Sodium sulfate {u} may cause a minor interaction that can limit clinical effects when taken with {v} Digitoxin
Sodium sulfate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Oxamniquine
Sodium sulfate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Fostemsavir
Sodium sulfate {u} may lead to a major life threatening interaction when taken with {v} Dronedarone
Sodium sulfate may cause a minor interaction that can limit clinical effects when taken with Digitoxin
Sodium sulfate may cause a moderate interaction that could exacerbate diseases when taken with Oxamniquine
Sodium sulfate may cause a moderate interaction that could exacerbate diseases when taken with Fostemsavir
Sodium sulfate may lead to a major life threatening interaction when taken with Dronedarone